Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) CEO Interview ✅ RICH TV LIVE
Channel: RICH TV LIVE
Date: 12/01/2022

Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) CEO Interview ✅ RICH TV LIVE - January 12, 2022 -  Filament Health Corp. ( OTCQB:FLHLF ) ( NEO:FH ) ( FSE:7QS ) ("Filament" or the "Company"), commends the formal restoration of access to restricted drugs through the Health Canada Special Access Program (SAP). The SAP allows health care practitioners to request for patients, on an emergency basis, access to drugs that are not yet approved in Canada . Since 2013, Canadians have been unable to access restricted drugs such as psilocybin and psilocin through the SAP. Thanks to the amendment, this access has been restored as of today. #filamenthealth #interview #richtvlive #ceo #business #news #finance #stocks #trading #money #psychedelics

"Clinical trials remain the best mechanism for access to psilocybin, psilocin, and other restricted psychedelic drugs before they are approved. To that end, we have partnered with several clinical trial operators in Canada to administer our natural psilocybin-containing drug candidates," said Benjamin Lightburn , Chief Executive Officer of Filament Health. "That being said, through the SAP, Canadians with serious or life-threatening conditions can request access to drugs that have not yet been approved for sale in Canada . We expect to receive a significant volume of inquiries regarding our unique botanical psychedelic drug candidates."

Filament Health is one of a limited number of Canadian companies to have in-house drug candidates in Health Canada approved clinical trials which are manufactured in accordance with Good Manufacturing Practices. For further information, contact sap@filament.health .

ABOUT FILAMENT HEALTH (OTCQB:FLHLF) (NEO:FH) (FSE:7QS)
Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates.

JOIN RICH TV LIVE TRADING CLUB HERE -  http://www.richpicksdaily.com 

Subscribe - https://www.youtube.com/c/RICHTVLIVE
Visit - www.richpicksdaily.com a community for stocks, cryptocurrency, news, and trending topics. #richtvlive #richpicksdaily #stocks #business #news #finance #education #entertainment #money #defi #nft #metaverse #trading #stockmarket

Popular Uploads - https://goo.gl/tbvXGg
Most Recent Upload - https://goo.gl/unKXBy
YouTube Channel Page - https://goo.gl/yUdG7w
Subscribe - http://www.youtube.com/c/RICHTVLIVE
Rich TV Live Playlist - https://goo.gl/e116JF
RICH TV LIVE TOP 10 STOCKS Playlist - https://www.youtube.com/playlist?list=PLiBGEhbXkQPCfeYmBKHyXXu8dZc3YkkbW&disable_polymer=true

Disclaimer

RICH TV LIVE INC. company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time. RICH TV LIVE INC. sponsored $2000 CAD for digital video services.

Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. 

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov/Canadian CSA https://www.securities-administrators.ca/.